Clinical Trials Directory

Trials / Unknown

UnknownNCT03802136

Multiple Biomarkers in ICU Sepsis Patients

Prognostic Value of Early Oxidative Stress Biomarkers in Patients With Sepsis

Status
Unknown
Phase
Study type
Observational
Enrollment
120 (estimated)
Sponsor
Zhongnan Hospital · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

Acute kidney injury (AKI) is a common condition among sepsis patients in the intensive care unit (ICU) and is associated with high morbidity and mortality. Oxidative stress biomarkers were investigated in panels and were reported to predict renal failure in sepsis patients. Some biomarkers would be able to identify who will recover and not recover better than serum creatinine. Thus, a combining oxidative stress biomarkers are needed to predict the occurrence or progression of AKI in critically ill patients.

Detailed description

Acute kidney injury (AKI) is a common condition among sepsis patients in the intensive care unit (ICU) and is associated with high morbidity and mortality. Oxidative stress biomarkers were investigated in panels and were reported to predict renal failure in sepsis patients. Research on AKI has focused on new damage biomarkers for early detection of AKI and worsening of renal function. Some biomarkers would be able to identify who will recover and not recover better than serum creatinine. Thus, a combining functional and damage markers as well as oxidative stress biomarkers are needed to predict the occurrence or progression of AKI in critically ill patients. Therefore, this prospective, observational study will be conducted in Mainland China

Conditions

Timeline

Start date
2018-12-30
Primary completion
2019-06-01
Completion
2019-06-01
First posted
2019-01-14
Last updated
2019-01-14

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT03802136. Inclusion in this directory is not an endorsement.

Multiple Biomarkers in ICU Sepsis Patients (NCT03802136) · Clinical Trials Directory